KT

Keith Tapper BMO Capital Latest Price Targets & Analyst Ratings

Stock Price Price Target Upside
Downside
Rating Date
NGNE icon
1
Neurogene
NGNE
$265M
$18.60 $16
14%
downside
Outperform 14 Apr ‘25
5 months ago
TSHA icon
2
Taysha Gene Therapies
TSHA
$887M
$3.25 $5
54%
upside
Outperform 27 Jun ‘24
1 year ago
ACAD icon
3
Acadia Pharmaceuticals
ACAD
$4.02B
$23.80 $31
30%
upside
Outperform 27 Jun ‘24
1 year ago